Search results for: Precision Medicine
Filter search results
Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?
1 June 2022
Share this: Download publication Sian Hodgson Nadine Henderson Adrian Towse Amanda Cole Gene therapies represent a new era of medicine, offering the potential for truly transformational health gains, and further…
Critical Factors Affecting Pharmaceutical R&D and the Availability of New Drugs
18 June 2013
…of R&D for medicines, including regulatory approval requirements, the patent system, the economics of R&D, the roles of the public and private sectors, “push” and “pull” incentives, and the influence…
To Heal and Harm: An Economic View of Drug Safety
1 December 2003
The aims of this book are to: • provide an historical background to modern pharmaceutical regulation; • summarise available data on the harm caused by medicines; • comment on treatment…
OHE at HESG: Value-based Assessment in the UK; Developing the EQ-5D-5L
23 January 2014
…(VBA) approach to valuing medicines may be implemented. As the presentation explains, VBA replaces ‘value-based pricing’, which as originally proposed in the UK was intended to achieve several objectives including…
Oriol de Solà-Morales
30 August 2023
…in Health Economics at Universitat Ramon Llull -IQS, and teaches in several courses nationally and internationally. Oriol is an MD specialised in Internal Medicine. I earned an MSc from the…
Innovation in Oncology: Real Option Value and Path Dependence
29 April 2014
…of new medicines given the limitations of the information available at launch. Based on an OHE Lunchtime Seminar, this Seminar Briefing addresses a persistent issue: how to adequately reward innovation…
Economic Evaluation of Growth Hormone Therapy
1 December 1991
…the GP’s clinical freedom to prescribe the medicines that he or she considers necessary for a patient’s treatment’, the families believe that FHSAs may feel that they should exert ‘downward…
OHE at ISPOR Europe: Presentations
19 November 2014
…(University of North Carolina, Chapel Hill) Panelists: Adrian Towse (OHE), Don Husereau, University of Ottawa and UMIT, Joshua J. Carlson (VeriTech Corporation). Regenerative medicine akt_nov14 from Office of Health Economics…
Universal Health Coverage: The Holy Grail? 21st Annual Lecture Publication.
31 January 2015
The 21st OHE Annual Lecture was given by Professor Anne Mills, London School of Hygiene and Tropical Medicine, on the subject of Universal Health Coverage in low- and middle-income countries….